Literature DB >> 25598305

Academic Performance among Children with Inflammatory Bowel Disease: A Population-Based Study.

Harminder Singh1, Zoann Nugent2, Marni Brownell3, Laura E Targownik4, Leslie L Roos3, Charles N Bernstein4.   

Abstract

OBJECTIVES: To determine grade 12 academic performance for children with inflammatory bowel disease (IBD). STUDY
DESIGN: Children diagnosed with IBD at age<17 years identified from the population-based University of Manitoba IBD Epidemiology Database were matched by age-, sex-, and area of residence to 10 randomly selected controls. Grade 12 educational outcomes (scores on the provincial grade 12 language arts and mathematics standards tests, and enrollment-in-grade-12-by- age-17) were determined by linkage to the province wide Manitoba Education Database. Linear and logistic regression analysis were used to compare the educational outcomes, adjusting for socioeconomic status and comorbidities and evaluate predictors of educational outcomes among children with IBD.
RESULTS: Grade 12 educational outcomes among 337 children with IBD were compared with 3093 without IBD. There were no significant differences among the 2 groups in the standardized scores (language arts: P=.31; mathematics: P=.48) or enrollment-in-grade-12-by- age-17 (P=.25). Lower socioeconomic status and diagnosis with mental health problems 6 months prior to and 6 months post-IBD diagnosis were independent predictors of worse educational outcomes. There was no significant effect of age of diagnosis of IBD, type of IBD (ulcerative colitis vs Crohn's disease), use of corticosteroids or immunomodulator agents, hospitalizations, or surgery for IBD.
CONCLUSIONS: Children with IBD on average achieve similar levels of academic achievement in grade 12 as those without IBD. This study underscores the educational impact of mental health conditions at IBD diagnosis among children.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25598305     DOI: 10.1016/j.jpeds.2014.12.010

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Data Resource Profile: The Manitoba Multigenerational Cohort.

Authors:  Amani F Hamad; Randy Walld; Lisa M Lix; Marcelo L Urquia; Leslie L Roos; Elizabeth Wall-Wieler
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

2.  Applying Telemedicine to Multidisciplinary Pediatric Inflammatory Bowel Disease Care.

Authors:  Hilary K Michel; Ross M Maltz; Brendan Boyle; Amy Donegan; Jennifer L Dotson
Journal:  Children (Basel)       Date:  2021-04-21

3.  School-related experience and performance with inflammatory bowel disease: results from a cross-sectional survey in 675 children and their parents.

Authors:  Magdalena Freckmann; Alexander Seipp; Martin W Laass; Sibylle Koletzko; Martin Claßen; Antje Ballauff; Jenny Peplies; Antje Timmer
Journal:  BMJ Open Gastroenterol       Date:  2018-11-24

4.  The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Authors:  Matthew W Carroll; M Ellen Kuenzig; David R Mack; Anthony R Otley; Anne M Griffiths; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Sanjay K Murthy; Geoffrey C Nguyen; Kate Lee; Jane Cooke-Lauder; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

5.  The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Authors:  M Ellen Kuenzig; Lawrence Lee; Wael El-Matary; Adam V Weizman; Eric I Benchimol; Gilaad G Kaplan; Geoffrey C Nguyen; Charles N Bernstein; Alain Bitton; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

6.  Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.

Authors:  Gertrude van den Brink; Luuk Stapersma; Anna Sophia Bom; Dimitris Rizopolous; C Janneke van der Woude; Rogier J L Stuyt; Danielle M Hendriks; Joyce A T van der Burg; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Elisabeth M W J Utens; Johanna C Escher
Journal:  Inflamm Bowel Dis       Date:  2019-11-14       Impact factor: 5.325

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.